Johnson & Johnson
JNJ
#20
Rank
HK$5.320 T
Marketcap
HK$2,210
Share price
2.04%
Change (1 day)
50.84%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

Johnson & Johnson (JNJ) - Total debt

Total debt on the balance sheet as of September 2026 : HK$350.12 Billion

According to Johnson & Johnson's latest financial reports the company's total debt is HK$350.12 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Johnson & Johnson - Total debt on balance sheet (from 1996 to 2026)

Total debt by year

Year Total debt Change
2025-12-31HK$372.95 B31.13%
2024-12-31HK$284.40 B24.15%
2023-12-31HK$229.08 B-26.04%
2022-12-31HK$309.73 B17.69%
2021-12-31HK$263.17 B-3.74%
2020-12-31HK$273.38 B26.75%
2019-12-31HK$215.69 B-9.63%
2018-12-31HK$238.68 B-11.66%
2017-12-31HK$270.17 B28.44%
2016-12-31HK$210.34 B36.65%
2015-12-31HK$153.93 B5.79%
2014-12-31HK$145.51 B3.22%
2013-12-31HK$140.97 B12.51%
2012-12-31HK$125.29 B-17.81%
2011-12-31HK$152.44 B16.79%
2010-12-31HK$130.53 B15.77%
2009-12-31HK$112.74 B23.1%
2008-12-31HK$91.58 B23.17%
2007-12-31HK$74.35 B45.02%
2006-12-31HK$51.27 B146.32%
2005-12-31HK$20.81 B-5.84%
2004-12-31HK$22.10 B-30.33%
2003-12-31HK$31.73 B-1.69%
2002-12-31HK$32.27 B48.8%
2001-12-31HK$21.69 B-40.21%
2000-12-31HK$36.28 B9.73%
1999-12-31HK$33.06 B-4.78%
1998-12-31HK$34.72 B143.53%
1997-12-31HK$14.25 B-19.21%
1996-12-31HK$17.65 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Novartis
NVS
HK$378.81 B 8.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$495.52 B 41.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$266.97 B-23.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
HK$220.75 B-36.95%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
HK$388.17 B 10.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$210.99 B-39.74%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
HK$205.80 B-41.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
HK$117.16 B-66.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$422.69 B 20.73%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$246.51 B-29.59%๐Ÿ‡ฌ๐Ÿ‡ง UK